Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

From Contraception to Breastfeeding: Experts Address Reproductive Health & Medication Management

Mithu Maheswaranathan, MD  |  Issue: December 2021  |  November 11, 2021

Lastly, patients with positive aPL or antiphospholipid antibody syndrome (APS) are also at increased risk for pregnancy complications and should be on low-dose aspirin to prevent pre-eclampsia. Anticoagulation is also recommended for obstetric patients with APS who have had multiple miscarriages or intrauterine demises, or thrombotic APS with a history of thrombosis.

“Hydroxychloroquine is conditionally recommended in patients with APS, given it has mild anticoagulant properties,” she said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

‘The reproductive health guideline recommends patients on mycophenolate also be prescribed a highly effective contraceptive method, such as an IUD, or two other forms of contraception, such as the pill & condoms.’ —Dr. Talabi

Medication Management

The following medications are safe to use during all phases of pregnancy and lactation: hydroxychloroquine, sulfasalazine, colchicine, azathioprine, prednisone, cyclosporine and tacrolimus. Additionally, all tumor necrosis factor (TNF) inhibitors can be used during pregnancy and lactation, although non-certolizumab TNF inhibitors are sometimes discontinued in the third trimester to avoid a potential risk of neonatal immunosuppression.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Medications contraindicated during pregnancy and breastfeeding include methotrexate, leflunomide, mycophenolate, cyclophosphamide and thalidomide. However, cyclophosphamide can be used in the second or third trimester for life- or organ-threatening disease. Small molecule agents, such as Janus kinase inhibitors (jakinibs) or apremilast, are likely to transfer across the placenta and breastmilk. These medications should not be used in pre-conception, during pregnancy or while breastfeeding (see Figure 1, below).

Figure 1: Maternal Medication Use Before & During Pregnancy, & During Breastfeeding1

One new update since the publication of the 2020 guideline was discussed: The FDA does not recommend non-steroidal anti-inflammatory drug (NSAID) use after 20 weeks of pregnancy because of the risk of oligohydramnios.

Men can safely use most medications during conception. However, cyclophosphamide and thalidomide should be discontinued before attempting to conceive. Because sulfasalazine (SSZ) can reduce sperm counts, semen analysis should be done if a man on SSZ has difficulty conceiving.

Real-World Examples

Next, Lisa Sammaritano, MD, professor of clinical medicine from the Hospital for Special Surgery, New York, and Weill Cornell Medicine, discussed applying the guideline to medication management.

Dr. Sammaritano provided an example of a patient with lupus who was breastfeeding her baby and required initiation of 25 mg of prednisone daily for post-partum flare. For doses of prednisone greater than 20 mg per day, patients should delay breastfeeding—or pump and discard—for four hours after taking the dose. She emphasized considering the addition of steroid-sparing, breastfeeding-compatible medications if prednisone cannot be quickly tapered. 

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2021breastfeedingcontraceptivepregnancyreproductive health

Related Articles

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    AndreyCherkasov / Shutterstock.com

    Rheumatic Disease Does Not Preclude Pregnancy

    November 9, 2017

    Preconception planning is essential to help women with autoimmune disease have optimal pregnancy outcomes. Unplanned pregnancy can also negatively impact disease course in some patients. Yet many rheumatologic patients of childbearing age do not receive adequate contraception or prepregnancy education and counseling. Rheumatologists must work collaboratively with other healthcare providers to make sure rheumatic patients…

    Challenges in Reproductive Health in Rheumatic Disease

    July 11, 2022

    In light of new challenges to individuals’ reproductive rights and the known challenges of clinical management of rheumatic disease patients during pregnancy, we review the current state of reproductive rheumatology and the management of patients with rheumatic disease during pregnancy.

    The ACR Has Introduced a New Reproductive Health Guideline Draft

    January 17, 2019

    CHICAGO—Reproductive health can be a concern for patients with rheumatic diseases, and practitioners in both disciplines often work closely together. The Reproductive Health in Rheumatic and Musculoskeletal Diseases Guideline, a draft of new clinical recommendations developed by an ACR-convened group for pregnant women, post-menopausal women, lactating women, and women and men trying to conceive or…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences